LogiPharma Report - Increasing visibility with a proactive supply chain

The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data. In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table. CEO Niclas Ohlsson, share TSS view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.

The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data. In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table. CEO Niclas Ohlsson, share TSS view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.

Highlights:

  • Recommendations on Implementing a Real-Time Monitoring Solution
  • A Glimpse into the Future of Pharma Logistics
  • The Evolving Digital Landscape
  • Increasing Visibility
  • Utilising Real-Time Data